X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2024-03-25 | SPRY | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $9.48 | +1,401,299 | 10,860,977 | +15% | +$13,289,410 | |||||
M | 2024-03-22 | SPRY | Lowenthal Richard E | Pres, CEO, 10% | S - Sale | $9.12 | -97,610 | 12,746,116 | -1% | -$890,322 | |||||
M | 2024-03-22 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.12 | -97,610 | 12,746,116 | -1% | -$890,322 | |||||
M | 2024-03-19 | SPRY | Lowenthal Richard E | Pres, CEO, 10% | S - Sale | $9.03 | -2,390 | 12,843,726 | 0% | -$21,572 | |||||
M | 2024-03-19 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.03 | -2,390 | 12,843,726 | 0% | -$21,572 | |||||
M | 2024-03-13 | SPRY | Lowenthal Richard E | Pres, CEO, 10% | S - Sale | $9.14 | -100,000 | 12,846,116 | -1% | -$913,681 | |||||
M | 2024-03-13 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.14 | -100,000 | 12,846,116 | -1% | -$913,681 | |||||
2024-02-29 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.02 | -3,782 | 12,946,116 | 0% | -$34,101 | ||||||
2024-02-29 | SPRY | Lowenthal Richard E | Pres, CEO, 10% | S - Sale | $9.02 | -3,782 | 12,946,116 | 0% | -$34,101 | ||||||
M | 2024-02-26 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.02 | -99,478 | 12,949,898 | -1% | -$897,368 | |||||
M | 2024-02-26 | SPRY | Lowenthal Richard E | Pres, CEO, 10% | S - Sale | $9.02 | -99,478 | 12,949,898 | -1% | -$897,368 | |||||
M | 2023-09-28 | SPRY | Fitzpatrick Alexander A | GC | P - Purchase | $3.71 | +86,258 | 89,227 | >999% | +$319,954 | |||||
2023-09-21 | SPRY | Ra Capital Management, L.P. | Dir | P - Purchase | $3.03 | +2,700,000 | 9,459,678 | +40% | +$8,183,526 | ||||||
D | 2023-09-01 | SPRY | Shawver Laura | Dir | S - Sale+OE | $7.71 | -100,000 | 210,346 | -32% | -$770,520 | |||||
2023-08-29 | SPRY | Ra Capital Management, L.P. | Dir | P - Purchase | $6.20 | +3,750,000 | 6,759,678 | +125% | +$23,250,000 | ||||||
2023-08-29 | SPRY | Orbimed Advisors LLC | Dir | P - Purchase | $6.20 | +500,000 | 9,240,887 | +6% | +$3,100,000 | ||||||
2023-08-29 | SPRY | Thompson Peter A. | Dir | P - Purchase | $6.20 | +500,000 | 9,240,887 | +6% | +$3,100,000 | ||||||
DM | 2023-08-03 | SPRY | Shawver Laura | Dir | S - Sale+OE | $7.03 | -45,004 | 210,346 | -18% | -$316,489 | |||||
DM | 2023-08-01 | SPRY | Shawver Laura | Dir | S - Sale+OE | $7.12 | -54,996 | 210,346 | -21% | -$391,841 | |||||
D | 2023-07-07 | SPRY | Shawver Laura | Dir | S - Sale+OE | $6.36 | -8,858 | 210,346 | -4% | -$56,372 | |||||
DM | 2023-07-03 | SPRY | Shawver Laura | Dir | S - Sale+OE | $6.48 | -91,142 | 210,346 | -30% | -$590,453 | |||||
DM | 2023-06-01 | SPRY | Shawver Laura | Dir | S - Sale+OE | $6.84 | -100,000 | 210,346 | -32% | -$684,041 | |||||
DM | 2022-11-09 | SPRY | Shawver Laura | Dir | S - Sale+OE | $5.42 | -143,896 | 210,346 | -41% | -$780,579 | |||||
2022-11-29 | SPRY | Scott Kathleen D. | CFO | P - Purchase | $6.24 | +8,250 | 8,250 | New | +$51,506 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |